ES2847698T3 - Construcción de ácido nucleico - Google Patents
Construcción de ácido nucleico Download PDFInfo
- Publication number
- ES2847698T3 ES2847698T3 ES16720483T ES16720483T ES2847698T3 ES 2847698 T3 ES2847698 T3 ES 2847698T3 ES 16720483 T ES16720483 T ES 16720483T ES 16720483 T ES16720483 T ES 16720483T ES 2847698 T3 ES2847698 T3 ES 2847698T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- nucleic acid
- transmembrane
- signal
- acid construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 53
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 45
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 45
- 238000010276 construction Methods 0.000 title description 3
- 108091005703 transmembrane proteins Proteins 0.000 claims abstract description 105
- 102000035160 transmembrane proteins Human genes 0.000 claims abstract description 104
- 230000031852 maintenance of location in cell Effects 0.000 claims abstract description 96
- 210000004027 cell Anatomy 0.000 claims abstract description 83
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 58
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 46
- 230000007017 scission Effects 0.000 claims abstract description 46
- 108010076039 Polyproteins Proteins 0.000 claims abstract description 26
- 108091005804 Peptidases Proteins 0.000 claims abstract description 14
- 239000004365 Protease Substances 0.000 claims abstract description 13
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 3
- 108090000623 proteins and genes Proteins 0.000 claims description 131
- 102000004169 proteins and genes Human genes 0.000 claims description 129
- 230000014509 gene expression Effects 0.000 claims description 56
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 47
- 230000014759 maintenance of location Effects 0.000 claims description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 28
- 229920001184 polypeptide Polymers 0.000 claims description 25
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims description 22
- 239000013598 vector Substances 0.000 claims description 22
- 210000003412 trans-golgi network Anatomy 0.000 claims description 17
- 230000002132 lysosomal effect Effects 0.000 claims description 14
- 108090001126 Furin Proteins 0.000 claims description 11
- 102000004961 Furin Human genes 0.000 claims description 11
- 108091005906 Type I transmembrane proteins Proteins 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 7
- 230000012202 endocytosis Effects 0.000 claims description 5
- 210000002288 golgi apparatus Anatomy 0.000 claims description 5
- 241000723792 Tobacco etch virus Species 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 description 127
- 230000003834 intracellular effect Effects 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 24
- 150000001413 amino acids Chemical class 0.000 description 23
- 108010076504 Protein Sorting Signals Proteins 0.000 description 18
- 230000001086 cytosolic effect Effects 0.000 description 18
- 210000003712 lysosome Anatomy 0.000 description 16
- 230000001868 lysosomic effect Effects 0.000 description 16
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 15
- 239000012528 membrane Substances 0.000 description 15
- 101100154912 Mus musculus Tyrp1 gene Proteins 0.000 description 14
- 210000000170 cell membrane Anatomy 0.000 description 14
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 13
- 210000001163 endosome Anatomy 0.000 description 12
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 12
- 102000035195 Peptidases Human genes 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000019419 proteases Nutrition 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 7
- 108010015340 Low Density Lipoprotein Receptor-Related Protein-1 Proteins 0.000 description 7
- 102000001851 Low Density Lipoprotein Receptor-Related Protein-1 Human genes 0.000 description 7
- 210000001744 T-lymphocyte Anatomy 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 241000710190 Cardiovirus Species 0.000 description 6
- 102100025024 Cation-dependent mannose-6-phosphate receptor Human genes 0.000 description 6
- 102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 description 6
- 101710145225 Cation-independent mannose-6-phosphate receptor Proteins 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 210000004899 c-terminal region Anatomy 0.000 description 6
- 108010090156 cation-dependent mannose-6-phosphate receptor Proteins 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 210000003463 organelle Anatomy 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- 241000710189 Aphthovirus Species 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 102000006495 integrins Human genes 0.000 description 5
- 108010044426 integrins Proteins 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- -1 41BB Proteins 0.000 description 4
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
- 101000984630 Homo sapiens Low-density lipoprotein receptor-related protein 10 Proteins 0.000 description 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 102100021918 Low-density lipoprotein receptor-related protein 4 Human genes 0.000 description 4
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 4
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 230000005945 translocation Effects 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 3
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 3
- 241000252212 Danio rerio Species 0.000 description 3
- 241000224495 Dictyostelium Species 0.000 description 3
- 241000710188 Encephalomyocarditis virus Species 0.000 description 3
- 101001043596 Homo sapiens Low-density lipoprotein receptor-related protein 3 Proteins 0.000 description 3
- 101000979599 Homo sapiens Protein NKG7 Proteins 0.000 description 3
- 101000837849 Homo sapiens Trans-Golgi network integral membrane protein 2 Proteins 0.000 description 3
- 101000807236 Human cytomegalovirus (strain AD169) Membrane glycoprotein US3 Proteins 0.000 description 3
- 102100020983 Lysosome membrane protein 2 Human genes 0.000 description 3
- 101710165448 Lysosome membrane protein 2 Proteins 0.000 description 3
- 101710116782 Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 3
- 102000018697 Membrane Proteins Human genes 0.000 description 3
- 102100023370 Protein NKG7 Human genes 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 3
- 102100028621 Trans-Golgi network integral membrane protein 2 Human genes 0.000 description 3
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000002121 endocytic effect Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 3
- 241001529453 unidentified herpesvirus Species 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
- 102100040164 ADP-ribosylation factor-binding protein GGA1 Human genes 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 108010027410 Adenovirus E3 Proteins Proteins 0.000 description 2
- 108010018673 Adenovirus Early Proteins Proteins 0.000 description 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 2
- 102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 2
- 102100039371 ER lumen protein-retaining receptor 1 Human genes 0.000 description 2
- 101710174216 Early E3 18.5 kDa glycoprotein Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101001037093 Homo sapiens ADP-ribosylation factor-binding protein GGA1 Proteins 0.000 description 2
- 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 2
- 101000868788 Homo sapiens Carboxypeptidase D Proteins 0.000 description 2
- 101000812437 Homo sapiens ER lumen protein-retaining receptor 1 Proteins 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 101001048464 Homo sapiens Homer protein homolog 2 Proteins 0.000 description 2
- 101000604998 Homo sapiens Lysosome-associated membrane glycoprotein 3 Proteins 0.000 description 2
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 2
- 101001038300 Homo sapiens Protein ERGIC-53 Proteins 0.000 description 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
- 101000639146 Homo sapiens Vesicle-associated membrane protein 4 Proteins 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 108010030685 KDEL receptor Proteins 0.000 description 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 108010015372 Low Density Lipoprotein Receptor-Related Protein-2 Proteins 0.000 description 2
- 102100021922 Low-density lipoprotein receptor-related protein 2 Human genes 0.000 description 2
- 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 2
- 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 2
- 101710116771 Lysosome-associated membrane glycoprotein 2 Proteins 0.000 description 2
- 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 2
- 102100038213 Lysosome-associated membrane glycoprotein 3 Human genes 0.000 description 2
- 102100025136 Macrosialin Human genes 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101710189920 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102000006437 Proprotein Convertases Human genes 0.000 description 2
- 108010044159 Proprotein Convertases Proteins 0.000 description 2
- 101710180647 Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 2
- 102100040252 Protein ERGIC-53 Human genes 0.000 description 2
- 108091006300 SLC2A4 Proteins 0.000 description 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
- 102100033939 Solute carrier family 2, facilitated glucose transporter member 4 Human genes 0.000 description 2
- 102100032889 Sortilin Human genes 0.000 description 2
- 108091008874 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
- 108010033576 Transferrin Receptors Proteins 0.000 description 2
- 241000223104 Trypanosoma Species 0.000 description 2
- 102100031489 Vesicle-associated membrane protein 4 Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010006523 asialoglycoprotein receptor Proteins 0.000 description 2
- 230000002886 autophagic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 108010057085 cytokine receptors Proteins 0.000 description 2
- 102000003675 cytokine receptors Human genes 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 108091008042 inhibitory receptors Proteins 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010056030 retronectin Proteins 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 108010014657 sortilin Proteins 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 108010087967 type I signal peptidase Proteins 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- INOZZBHURUDQQR-AJNGGQMLSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 INOZZBHURUDQQR-AJNGGQMLSA-N 0.000 description 1
- QXXBUXBKXUHVQH-FMTGAZOMSA-N (2s)-2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-3-hydroxy-2-[[2-[[2-[[(2s)-1-[(2s)-1-[(2s)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-methylbutan Chemical compound C([C@H]1C(=O)N2CCC[C@H]2C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)C(C)C)CCN1C(=O)[C@@H]1CCC(=O)N1 QXXBUXBKXUHVQH-FMTGAZOMSA-N 0.000 description 1
- WDVIDPRACNGFPP-QWRGUYRKSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WDVIDPRACNGFPP-QWRGUYRKSA-N 0.000 description 1
- 102100040190 ADP-ribosylation factor-binding protein GGA2 Human genes 0.000 description 1
- 102100040193 ADP-ribosylation factor-binding protein GGA3 Human genes 0.000 description 1
- 102000012002 Aquaporin 4 Human genes 0.000 description 1
- 108010036280 Aquaporin 4 Proteins 0.000 description 1
- 101100391565 Arabidopsis thaliana FZR3 gene Proteins 0.000 description 1
- 108010002913 Asialoglycoproteins Proteins 0.000 description 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 102100027207 CD27 antigen Human genes 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 102000008203 CTLA-4 Antigen Human genes 0.000 description 1
- 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
- 229940045513 CTLA4 antagonist Drugs 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 102100034330 Chromaffin granule amine transporter Human genes 0.000 description 1
- 108090000227 Chymases Proteins 0.000 description 1
- 102000003858 Chymases Human genes 0.000 description 1
- 101100523286 Coturnix japonica QNR-71 gene Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
- 101100316741 Danio rerio slc18a3b gene Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 101000606134 Gallus gallus Tyrosinase Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000003834 Histamine H1 Receptors Human genes 0.000 description 1
- 108090000110 Histamine H1 Receptors Proteins 0.000 description 1
- 101001037082 Homo sapiens ADP-ribosylation factor-binding protein GGA2 Proteins 0.000 description 1
- 101001037079 Homo sapiens ADP-ribosylation factor-binding protein GGA3 Proteins 0.000 description 1
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
- 101000823051 Homo sapiens Amyloid-beta precursor protein Proteins 0.000 description 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
- 101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
- 101000936277 Homo sapiens Copper-transporting ATPase 1 Proteins 0.000 description 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
- 101001022148 Homo sapiens Furin Proteins 0.000 description 1
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 description 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 1
- 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 1
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 description 1
- 101001005711 Homo sapiens MARVEL domain-containing protein 2 Proteins 0.000 description 1
- 101000959111 Homo sapiens Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 1
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 1
- 101001098872 Homo sapiens Proprotein convertase subtilisin/kexin type 7 Proteins 0.000 description 1
- 101100209984 Homo sapiens SLC18A1 gene Proteins 0.000 description 1
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
- 101000868139 Homo sapiens Sortilin Proteins 0.000 description 1
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 1
- 101000606090 Homo sapiens Tyrosinase Proteins 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 102100022339 Integrin alpha-L Human genes 0.000 description 1
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 description 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 102000000853 LDL receptors Human genes 0.000 description 1
- 108010001831 LDL receptors Proteins 0.000 description 1
- 102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 1
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 1
- 102100021917 Low-density lipoprotein receptor-related protein 3 Human genes 0.000 description 1
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 description 1
- 102100025070 MARVEL domain-containing protein 2 Human genes 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 108090000591 Metallocarboxypeptidase D Proteins 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 102100031521 Morphogenetic neuropeptide Human genes 0.000 description 1
- 101710105851 Morphogenetic neuropeptide Proteins 0.000 description 1
- 102100026502 Mucolipin-1 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101000749871 Mus musculus Contactin-associated protein 1 Proteins 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 102000035028 Nucleic proteins Human genes 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000276569 Oryzias latipes Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000699692 Peromyscus maniculatus Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 102000007584 Prealbumin Human genes 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 102100040678 Programmed cell death protein 1 Human genes 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- 101800001065 Protein 2B Proteins 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 108091006772 SLC18A1 Proteins 0.000 description 1
- 108091006308 SLC2A8 Proteins 0.000 description 1
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 102100023105 Sialin Human genes 0.000 description 1
- 101710105284 Sialin Proteins 0.000 description 1
- 101150088805 Slc18a3 gene Proteins 0.000 description 1
- 102100030936 Solute carrier family 2, facilitated glucose transporter member 8 Human genes 0.000 description 1
- 102100025639 Sortilin-related receptor Human genes 0.000 description 1
- 101710126735 Sortilin-related receptor Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 101001051488 Takifugu rubripes Neural cell adhesion molecule L1 Proteins 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
- 108091005956 Type II transmembrane proteins Proteins 0.000 description 1
- 108091006383 Type IV transmembrane proteins Proteins 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 108010041601 histidyl-aspartyl-glutamyl-leucine Proteins 0.000 description 1
- 102000046783 human APP Human genes 0.000 description 1
- 102000055255 human ATP7A Human genes 0.000 description 1
- 102000057640 human CD63 Human genes 0.000 description 1
- 102000055412 human PAM Human genes 0.000 description 1
- 102000054226 human PCSK7 Human genes 0.000 description 1
- 102000045553 human SLC18A1 Human genes 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004020 intracellular membrane Anatomy 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 108010028930 invariant chain Proteins 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000006674 lysosomal degradation Effects 0.000 description 1
- 108010045758 lysosomal proteins Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000009061 membrane transport Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 102000035085 multipass transmembrane proteins Human genes 0.000 description 1
- 108091005494 multipass transmembrane proteins Proteins 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000680 phagosome Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 230000018883 protein targeting Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
- 230000009131 signaling function Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/31—Chimeric antigen receptors [CAR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/421—Immunoglobulin superfamily
- A61K40/4211—CD19 or B4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/06—Fusion polypeptide containing a localisation/targetting motif containing a lysosomal/endosomal localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1507104.6A GB201507104D0 (en) | 2015-04-27 | 2015-04-27 | Nucleic acid construct |
| PCT/GB2016/051164 WO2016174408A1 (en) | 2015-04-27 | 2016-04-26 | Nucleic acid construct |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2847698T3 true ES2847698T3 (es) | 2021-08-03 |
Family
ID=53488689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16720483T Active ES2847698T3 (es) | 2015-04-27 | 2016-04-26 | Construcción de ácido nucleico |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11530420B2 (enExample) |
| EP (1) | EP3288968B1 (enExample) |
| JP (2) | JP6836515B2 (enExample) |
| CN (1) | CN107532176A (enExample) |
| AU (1) | AU2016254498B2 (enExample) |
| CA (1) | CA2984101A1 (enExample) |
| ES (1) | ES2847698T3 (enExample) |
| GB (1) | GB201507104D0 (enExample) |
| HK (1) | HK1244021A1 (enExample) |
| WO (1) | WO2016174408A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3143134B1 (en) | 2014-05-15 | 2020-10-28 | National University of Singapore | Modified natural killer cells and uses thereof |
| GB201507108D0 (en) | 2015-04-27 | 2015-06-10 | Ucl Business Plc | Nucleic acid construct |
| EA201890640A1 (ru) * | 2015-09-04 | 2018-09-28 | Токаджен Инк. | Рекомбинантные векторы, содержащие пептид 2а |
| SG10201912387PA (en) | 2016-11-22 | 2020-02-27 | Nat Univ Singapore | Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies |
| WO2018175988A1 (en) * | 2017-03-24 | 2018-09-27 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-cd33 immunotherapy |
| SG11201908492PA (en) | 2017-03-27 | 2019-10-30 | Nat Univ Singapore | Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy |
| EP3601537A4 (en) | 2017-03-27 | 2021-01-13 | National University of Singapore | STIMULATING CELL LINES FOR EX VIVO EXPANSION AND ACTIVATION OF NATURAL KILLER CELLS |
| EP3700561A1 (en) * | 2017-10-27 | 2020-09-02 | Statens Serum Institut | A polygene influenza vaccine |
| CN108359014A (zh) * | 2018-02-08 | 2018-08-03 | 四川农业大学 | 含有dhav-1 2a1-p的多肽及其介导的多蛋白共表达方法 |
| CN111801348A (zh) | 2018-02-09 | 2020-10-20 | 新加坡国立大学 | 活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途 |
| KR20200138741A (ko) | 2018-04-02 | 2020-12-10 | 내셔널 유니버시티 오브 싱가포르 | 면역 세포에서 발현되는 막-결합 항-사이토카인 비-신호전달 결합제를 이용한 인간 사이토카인의 중화 |
| GB201805918D0 (en) * | 2018-04-10 | 2018-05-23 | Autolus Ltd | Cell |
| US20220175960A1 (en) * | 2018-08-24 | 2022-06-09 | Locanabio, Inc. | Fasl immunomodulatory gene therapy compositions and methods for use |
| JP7560882B2 (ja) | 2018-08-29 | 2024-10-03 | ナショナル ユニヴァーシティー オブ シンガポール | 遺伝子修飾免疫細胞の生存及び増加を特異的に刺激するための方法 |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | ANTI-CD19 CHEMERIC ANTIGEN RECEPTORS AND THEIR USE IN IMMUNOTHERAPY |
| GB201914611D0 (en) * | 2019-10-09 | 2019-11-20 | Autolus Ltd | Engineered immune cell |
| WO2024197792A1 (en) * | 2023-03-31 | 2024-10-03 | Beijing University Of Chinese Medicine | A complex comprising a cell penetrating peptide and a copi sorting inhibitor and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU733719B2 (en) * | 1996-10-23 | 2001-05-24 | Trustees Of The University Of Pennsylvania, The | Improved vaccines |
| US20070065912A1 (en) * | 2005-07-21 | 2007-03-22 | Abbott Laboratories | Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis |
| CN103483452B (zh) * | 2012-06-12 | 2021-08-13 | 上海细胞治疗集团有限公司 | 双信号独立的嵌合抗原受体及其用途 |
| MX2015006301A (es) * | 2012-11-21 | 2015-09-07 | Merz Pharma Gmbh & Co Kgaa | Medios y metodos para la determinacion de la actividad biologica de la neurotoxina botulinica. |
| CN106132423B (zh) * | 2014-02-14 | 2020-07-31 | 贝里坤制药股份有限公司 | 用诱导型嵌合多肽活化t细胞的方法 |
| WO2016123010A1 (en) | 2015-01-26 | 2016-08-04 | United States Mineral Products Company | Corrosion resistant spray applied fire resistive materials |
-
2015
- 2015-04-27 GB GBGB1507104.6A patent/GB201507104D0/en not_active Ceased
-
2016
- 2016-04-26 CN CN201680024069.5A patent/CN107532176A/zh active Pending
- 2016-04-26 EP EP16720483.3A patent/EP3288968B1/en active Active
- 2016-04-26 CA CA2984101A patent/CA2984101A1/en not_active Abandoned
- 2016-04-26 US US15/568,859 patent/US11530420B2/en active Active
- 2016-04-26 JP JP2017555766A patent/JP6836515B2/ja active Active
- 2016-04-26 ES ES16720483T patent/ES2847698T3/es active Active
- 2016-04-26 WO PCT/GB2016/051164 patent/WO2016174408A1/en not_active Ceased
- 2016-04-26 AU AU2016254498A patent/AU2016254498B2/en not_active Ceased
- 2016-04-26 HK HK18103619.5A patent/HK1244021A1/zh unknown
-
2020
- 2020-07-07 JP JP2020117039A patent/JP2020171313A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN107532176A (zh) | 2018-01-02 |
| EP3288968B1 (en) | 2020-11-25 |
| EP3288968A1 (en) | 2018-03-07 |
| WO2016174408A1 (en) | 2016-11-03 |
| JP2018514208A (ja) | 2018-06-07 |
| US11530420B2 (en) | 2022-12-20 |
| US20180100163A1 (en) | 2018-04-12 |
| JP2020171313A (ja) | 2020-10-22 |
| GB201507104D0 (en) | 2015-06-10 |
| CA2984101A1 (en) | 2016-11-03 |
| JP6836515B2 (ja) | 2021-03-03 |
| HK1244021A1 (zh) | 2018-07-27 |
| AU2016254498B2 (en) | 2020-10-22 |
| AU2016254498A1 (en) | 2017-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2847698T3 (es) | Construcción de ácido nucleico | |
| ES2777801T3 (es) | Construcción de ácido nucleico para la expresión de más de un receptor de antígeno quimérico | |
| ES2778905T3 (es) | Constructo de ácido nucleico para la expresión de más de un receptor de antígeno quimérico | |
| ES2869971T3 (es) | Construcción de ácido nucleico | |
| US20180111993A1 (en) | Nucleic acid construct for expressing more than one chimeric antigen receptor | |
| US20240091357A1 (en) | Engineered immune cell | |
| US20240018197A1 (en) | Hook fusion protein for regulating the cellular trafficking of a target protein | |
| US20180371056A1 (en) | Multi-Span Chimeric Antigen Receptor | |
| WO2022167798A1 (en) | Molecule | |
| KR100843634B1 (ko) | 세포막투과 전달 펩타이드 및 이를 포함하는 생물제제 |